SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,301.40 383.55
( 0.50%)

Global Indices

Nasdaq

53,347.89 1,540.17
(2.97%)

Dow Jones

7,717.41 127.49
(1.68%)

Hang Seng

62,088.48 -993.38
(-1.57%)

Nikkei 225

10,852.07 213.64
(2.01%)

Forex

USD-INR

94.80 -0.14
(-0.14%)

EUR-INR

106.11 0.21
(0.20%)

GBP-INR

127.09 0.00
(0.00%)

JPY-INR

0.60 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

432.144993

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

39.61

113109.96

EPS(TTM)

Face Value()

Div & Yield %

35.35

0.93

Back

Cipla consolidated net profit declines 35.05% in the September 2026 quarter

Oct 27,2026

Net profit of Cipla declined 35.05% to Rs 877.54 crore in the quarter ended September 2026 as against Rs 1351.17 crore during the previous quarter ended September 2025. Sales declined 1.06% to Rs 7368.15 crore in the quarter ended September 2026 as against Rs 7447.42 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	7368.15	7447.42	-1
OPM %	18.83	25.44	-
PBDT	1522.20	2150.52	-29
PBT	1177.34	1853.53	-36
NP	877.54	1351.17	-35

77,301.40 383.55 ( 0.50%)

53,347.89 1,540.17 (2.97%)

7,717.41 127.49 (1.68%)

62,088.48 -993.38 (-1.57%)

10,852.07 213.64 (2.01%)

94.80 -0.14 (-0.14%)

106.11 0.21 (0.20%)

127.09 0.00 (0.00%)

0.60 0.00 (-0.29%)